Systemic sclerosis and the heart

Heart disease, either clinically apparent or silent, is a frequent complication of systemic sclerosis (SSc, scleroderma) and may affect both patients with diffuse cutaneous and limited cutaneous SSc. The availability of more sensitive modalities has led to an increased awareness of scleroderma heart...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Rheumatic diseases clinics of North America Ročník 40; číslo 1; s. 87
Hlavní autoři: Parks, John L, Taylor, Marian H, Parks, Laura P, Silver, Richard M
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 01.02.2014
Témata:
Cardiomyopathies - etiology
Heart Diseases - diagnosis
Heart Diseases - etiology
Heart Diseases - therapy
Heart Valve Diseases - etiology
Humans
Prognosis
Scleroderma, Systemic - complications
Ventricular Dysfunction - etiology
Pericarditis
Myocardial fibrosis
Conduction abnormalities
Scleroderma
Heart disease
Systemic sclerosis
ISSN:1558-3163, 1558-3163
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Heart disease, either clinically apparent or silent, is a frequent complication of systemic sclerosis (SSc, scleroderma) and may affect both patients with diffuse cutaneous and limited cutaneous SSc. The availability of more sensitive modalities has led to an increased awareness of scleroderma heart disease, which often involves the pericardium, myocardium, and cardiac conduction system. This awareness of cardiac involvement requires attention and interventions led by internists, cardiologists, and rheumatologists. Although no specific therapy exists for scleroderma heart disease, early recognition of the presence and type of scleroderma heart disease may lead to more effective management of patients with scleroderma.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1558-3163
1558-3163
DOI:10.1016/j.rdc.2013.10.007